Chitosan nanoparticles and based composites as a biocompatible vehicle for drug delivery: a review

R Pathak, S Bhatt, VD Punetha, M Punetha - International Journal of …, 2023 - Elsevier
The shellfish processing industry is one of the largest growing industries across the globe
with a market size of around USD 62B. However, it also leads to a significant environmental …

Nano‐biotechnology and challenges of drug delivery system in cancer treatment pathway

E Asadipour, M Asgari, P Mousavi… - Chemistry & …, 2023 - Wiley Online Library
In this review, we discuss Nanotechnology models, which have been developed recently in
cancer treatment. Nanotechnology manipulates matter at the atomic and molecular scale to …

Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii

T Piri-Gharaghie, A Doosti, SA Mirzaei - AMB Express, 2023 - Springer
Developing adjuvant vaccines to combat rising multidrug-resistant (MDR) Acinetobacter
baumannii (A. baumannii) infections is a promising and cost-effective approach. The aim of …

An emerging era in manufacturing of drug delivery systems: Nanofabrication techniques

P Pingale, P Kendre, K Pardeshi, A Rajput - Heliyon, 2023 - cell.com
Nanotechnology has the capability of making significant contributions to healthcare.
Nanofabrication of multifunctional nano-or micro-character systems is becoming incredibly …

Exploring modified chitosan-based gene delivery technologies for therapeutic advancements

AD Gholap, HS Kapare, S Pagar, P Kamandar… - International Journal of …, 2024 - Elsevier
One of the critical steps in gene therapy is the successful delivery of the genes.
Immunogenicity and toxicity are major issues for viral gene delivery systems. Thus, non-viral …

Novel csuC-DNA nanovaccine based on chitosan candidate vaccine against infection with Acinetobacter baumannii

E Hosseinnezhad-Lazarjani, A Doosti, A Sharifzadeh - Vaccine, 2023 - Elsevier
Background Generating vaccines is a promising and effective method for stopping the
spread of Acinetobacter baumannii (A. baumannii) infections that are becoming more and …

Use of immunoinformatics and the simulation approach to identify Helicobacter pylori epitopes to design a multi-epitope subunit vaccine for B- and T-cells

ZA Chaleshtori, AA Rastegari, H Nayeri, A Doosti - BMC biotechnology, 2023 - Springer
Background Helicobacter pylori cause a variety of gastric malignancies, gastric ulcers, and
cause erosive diseases. The extreme nature of the bacterium and the implantation of this …

[PDF][PDF] Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express-ureF DNA Vaccines

M Afkhamipour, F Kaviani, S Dalali… - Arch. Immunol. Ther …, 2024 - scholar.archive.org
Most gastric cancers (GC) are thought to be caused by Helicobacter pylori (H. pylori)
infections. However, there is mounting evidence that GC patients with positive H. pylori …

[HTML][HTML] PIRES2-EGFP/CTB-UreI vaccination activated a mixed Th1/Th2/Th17 immune system defense towards Helicobacter pylori infection in the BALB/c mice model

S Ghasemifar, O Chabak, T Piri-Gharaghie, A Doosti - Vaccine, 2024 - Elsevier
The occurrence of gastritis, gastric ulcers, distal gastric cancer, and gastric mucosal
lymphoma in humans is strongly associated with Helicobacter pylori (H. pylori). Vaccination …

Chitosan-LeoA-DNA Nanoparticles Promoted the Efficacy of Novel LeoA-DNA Vaccination on Mice Against Helicobacter pylori

ZA Chaleshtori, AA Rastegari, H Nayeri, A Doosti - Current Microbiology, 2024 - Springer
More than half of the world's population is infected with Helicobacter pylori (H. pylori), which
may lead to chronic gastritis, peptic ulcers, and stomach cancer. LeoA, a conserved antigen …